(Q3088229)

Statements

instance of

type of chemical entity

0 references

subclass of

uricase

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148794

retrieved

27 February 2018

has use

medication

1 reference

title

Rasburicase (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00049

image of molecular model or crystal lattice model

Rasburicase.png
382 × 337; 24 KB

depicts

space-filling model

0 references

defined daily dose

14 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=V03AF07

active ingredient in

Fasturtec

1 reference

European Medicines Agency product number

EMEA/H/C/000331

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000331/human_med_000787.jsp

retrieved

22 March 2017

medical condition treated

hyperuricemia

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148794

language of work or name

English

retrieved

13 December 2016

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

title

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

stated in

LiverTox

retrieved

8 April 2021

reference URL

https://www.ncbi.nlm.nih.gov/books/n/livertox/Rasburicase

last update

21 May 2018

has characteristic

biopharmaceutical

1 reference

title

Rasburicase (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00049

subject has role

enzyme activator

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148794

retrieved

5 March 2018

Identifiers